Cite
A Phase I Trial of Weekly Nab-paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-small Cell Lung Cancer.
MLA
Kubota, Tetsuya, et al. “A Phase I Trial of Weekly Nab-Paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-Small Cell Lung Cancer.” In Vivo (Athens, Greece), vol. 38, no. 1, Jan. 2024, pp. 259–63. EBSCOhost, https://doi.org/10.21873/invivo.13433.
APA
Kubota, T., Sakai, M., Anabuki, K., Takamatsu, K., Mukaida, K., Kobayashi, K., Yamagami, T., & Yokoyama, A. (2024). A Phase I Trial of Weekly Nab-paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-small Cell Lung Cancer. In Vivo (Athens, Greece), 38(1), 259–263. https://doi.org/10.21873/invivo.13433
Chicago
Kubota, Tetsuya, Mizu Sakai, Kazuki Anabuki, Kazufumi Takamatsu, Kenichi Mukaida, Kana Kobayashi, Takuji Yamagami, and Akihito Yokoyama. 2024. “A Phase I Trial of Weekly Nab-Paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-Small Cell Lung Cancer.” In Vivo (Athens, Greece) 38 (1): 259–63. doi:10.21873/invivo.13433.